Global Recognition Helps Propel the Expansion of the CBD and Cannabis Market
- FinancialBuzz.com News Commentary
NEW YORK, Jan. 6, 2021 /PRNewswire/ The cannabis industry has had some major accomplishments in recent years. 16 states have now fully legalized the use of cannabis products for both medical and recreational use. Furthermore, in last year s election, New Jersey, a major potential market for the industry voted in favor of legalization as well. However, because of how complex the legal infrastructure is in regards to the cannabis market, it is still impossible to purchase any legal products and people can still be arrested for cannabis possession in the state. It s sort of unclear whether there s now a constitutional right to possess cannabis, said Amol Sinha, the Executive Director of the American Civil Liberties Union of New Jersey, according to a report by Forbes. But I think it behooves the government to pass something quickly, so we don t have to engage in litiga
Do These Top Marijuana Stock Hold Value In The Cannabis Industry marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.
GW Pharmaceuticals plc (NASDAQ:GWPH) said Monday that the results of the company’s positive Phase 3 clinical trial of Epidiolex oral solution in seizures related to tuberous sclerosis complex were published in JAMA Neurology.
Epidiolex is the first FDA-authorized CBD medicine for treating children with severe forms of epilepsy. The medicine was first approved for treatments of seizures connected to Lennox-Gastaut syndrome and Dravet syndrome.
Tuberous sclerosis complex is a genetic condition that causes the growth of tumors, usually benign ones, in vital organs, further causing genetic epilepsy.
Around 1 million people in the world suffer from the condition, which causes various types of seizures.